Drug-gene interaction the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and antihypertensive therapy
The Annals of Pharmacotherapy , Volume 40 - Issue 2 p. 212- 218
BACKGROUND: Despite the availability of a variety of effective drugs, inadequate control of blood pressure is common. There are some indications that the angiotensin-converting enzyme (ACE) gene modifies the response to antihypertensive drugs, but the results have been inconclusive. OBJECTIVE: To investigate whether the insertion/deletion polymorphism of the ACE gene modifies blood pressure differences among subjects using diuretics, β-blockers, calcium-channel antagonists, or ACE inhibitors. METHODS: Data were used from the Rotterdam Study, a population-based, prospective, cohort study in the Netherlands, which started in 1990 and included 7983 subjects aged 55 years or older. Data from 3 subsequent cross-sectional investigations were used, as well. Subjects were included if they had high blood pressure during one or more examinations and/or used monotherapy with a diuretic, β-blocker, calcium-channel antagonist, or ACE inhibitor. A marginal, generalized, linear model was used to assess the association between the mean difference in systolic/diastolic blood pressure and antihypertensive classes stratified by the 3 genotypes. RESULTS: In total, 3025 hypertensive individuals were included, and 6500 measurements of blood pressure were taken. The percentages of DD, ID, and II genotypes were 28.3%, 51.4%, and 20.3%, respectively. The mean differences in systolic blood pressure between the II and DD genotypes were 0.23 mm Hg (95% Cl -5.48 to 5.94) for diuretics, -2.41 mm Hg (95% Cl -6.72 to 1.90) for β-blockers, 2.12 mm Hg (95% Cl -4.64 to 8.89) for calcium-channel antagonists, and -2.01 mm Hg (95% Cl -9.82 to 5.79) for ACE inhibitors. CONCLUSIONS: The adjusted mean difference in diastolic and systolic blood pressure among diuretic, β-blocker, calcium-channel antagonist, or ACE inhibitor users was not modified by the ACE insertion/deletion polymorphism.
|Angiotensin-converting enzyme gene, Polymorphism|
|The Annals of Pharmacotherapy|
|Organisation||Erasmus MC: University Medical Center Rotterdam|
Schelleman, H, Klungel, O.H, van Duijn, C.M, Witteman, J.C.M, Hofman, A, de Boer, A.C, & Stricker, B.H.Ch. (2006). Drug-gene interaction the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and antihypertensive therapy. The Annals of Pharmacotherapy, 40(2), 212–218. doi:10.1345/aph.1G316